Skip to content

Medical-device intelligence

PMT: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens

FDA product code PMT: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PMT
FDA device name
Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens
Device class
2
Regulation number
866.3215
Medical specialty
Microbiology
Review panel
MI

FDA definition

An assay used to determine the level of procalcitonin (PCT) in human serum and plasma as an aid in assessing the mortality for patients diagnosed with severe sepsis or septic shock.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 1 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Jun 13, 2016 to Feb 25, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
VITROS BRAHMS PCT Reagent Pack and CalibratorsK200236 · PMTOrtho Clinical Diagnostics510(k)Feb 25, 2020FDA decision date
Atellica IM BRAHMS Procalcitonin (PCT)K181002 · PMTSiemens Healthcare Diagnostics, Inc.510(k)Jul 16, 2018FDA decision date
Elecsys BRAHMS PCT Immunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma (K2 and K3 EDTA, Li-…Z-1311-2018 · PMTRoche Diagnostics CorporationRecallApr 4, 2018FDA record creation date
VIDAS B.R.A.H.M.S. PCT (PCT)K160911 · PMTbioMerieux, Inc.510(k)Jun 28, 2016FDA decision date
Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5K160729 · PMTRoche Diagnostics510(k)Jun 13, 2016FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗